Abstract
Recent advances in lipid nanoparticle research suggest that colloidal carriers have great potential for administration of drug molecules. The use of physiological lipids in their matrices presents the advantages of biocompatibility and reduced toxicity. The lipids are known to influence drug encapsulation, particle morphology and drug release properties, as do other excipients such as surfactants, water and drug molecules. The rationale behind using lipid nanoparticles is the improved delivery of poorly water-soluble drugs. In addition, the lipid nanoparticles are expected to protect the drug from harsh biological conditions. The stability of lipid nanoparticles and the incorporated drug ensures improved drug efficacy. This chapter focuses on the physicochemical stability of lipid nanoparticle dispersions. The dispersion stability of pharmaceutical products is usually achieved by either of two stabilization mechanisms—electrostatic and/or steric stabilization. The destabilization mechanism, though undesirable when formulations are on shelf, can play a crucial role to in vivo applications where limited destabilisation is required for controlled drug release. A number of techniques such as water elimination or addition of specific stabilizers have been employed to optimize stabilization of lipid nanoparticle formulations. Although different measures have been taken to achieve the desired physicochemical stability, appropriate use of characterization tools to detect any destabilization in the system is necessary and will be discussed briefly here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdelwahed W, Degobert G, Stainmesse S, Fessi H (2006) Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv Drug Deliver Rev 58(15):1688–1713
Araújo J, Gonzalez E, Egea M, Garcia M, Souto E (2009) Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomed Nanotechnol 5(4):394–401
Araújo J, Nikolic S, Egea M, Souto E, Garcia M (2011) Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye. Colloid Surf B 88(1):150–157
Attama A, Reichl S, Müller-Goymann C (2008) Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm 355(1–2):307–313
Awad T, Helgason T, Kristbergsson K, Decker E, Weiss J, McClements D (2008) Effect of cooling and heating rates on polymorphic transformations and gelation of triplamitin solid lipid nanoparticle (SLN) suspensions. Food Biophys 3:155–162
Blasi P, Schoubben A, Romano G, Giovagnoli S, Di Michele A, Ricci M (2013) Lipid nanoparticles for brain targeting II. Technological characterization. Colloid Surf B. 110:130–137
Bunjes H, Koch M, Westesen K (2000) Effect of particle size on colloidal solid triglycerides. Langmuir 16(12):5234–5241
Bunjes H, Siekmann B (2005) Manufacture, characterization, and applications of solid lipid nanoparticles as drug delivery systems. Microencapsulation: methods and industrial applications. Drugs and the pharmaceutical sciences. CRC Press, New York, pp 213–268
Bunjes H, Unruh T (2007) Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev 59(6):379–402
Bunjes H, Westesen K, Koch M (1996) Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 129(1):159–173
Cavalli R, Gasco M, Chetoni P, Burgalassi S, Saettone M (2002) Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 238(1–2):241–245
Choi K-O, Aditya N, Ko S (2014) Effect of aqueous pH and electrolyte concentration on structure, stability and flow behavior of non-ionic surfactant based solid lipid nanoparticles. Food Chem 147:239–244
Das S, Chaudhury A (2011) Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS Pharm Sci Tech 12(1):62–76
Deraguin B, Landau L (1941) Theory of the stability of strongly charged lyophobic sols and of the adhesion of strongly charged particles in solution of electrolytes. Acta Phys Chim: USSR 14:633–662
Freitas C, Müller R (1998) Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int J Pharm 168(2):221–229
Freitas C, Müller R (1999) Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase. Eur J Pharm Biopharm 47(2):125–132
Gambinossi F, Chanana M, Mylon S, Ferri J (2014) Stimulus-responsive Au@(MeO2MAx-co-OEGMAy) nanoparticles stabilized by non-DLVO interactions: implications of ionic strength and copolymer (x:y) fraction on aggregation kinetics. Langmuir 30(7):1748–1757
Garad S, Wang J, Joshi Y, Panicucci R (2010) Preclinical development for suspensions. In: Kulshreshtha A, Singh O, Wall G (eds) Pharmaceutical suspensions—from pharmaceutical development to manufacturing. Springer, New York, pp 127–176
Han F, Li S, Yin R, Liu H, Xu L (2008) Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers. Colloid Surf A 315(1–3):210–216
Hao J, Wang X, Bi Y, Teng Y, Wang J, Li F et al (2014) Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery. Colloid Surf B 114:111–120
Helgason T, Awad T, Kristbergsson K, Decker E, McClements D, Weiss J (2009a) Impact of surfactant properties on oxidative stability of β-carotene encapsulated within solid lipid nanoparticles. J Agr Food Chem 57(17):8033–8040
Helgason T, Awad T, Kristbergsson K, McClements D, Weiss J (2008) Influence of polymorphic transformations on Gelation of tripalmitin solid lipid nanoparticle suspensions. J Am Oil Chem Soc 85(6):501–511
Helgason T, Awad T, Kristbergsson K, McClements D, Weiss J (2009b) Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). J Colloid Interface Sci 334(1):75–81
Heurtault B, Saulnier P, Pech B, Proust J-E, Benoit J-P (2003) Physico-chemical stability of colloidal lipid particles. Biomaterials 24(23):4283–4300
Jaafar-Maalej C, Elaissari A, Fessi H (2012) Lipid-based carriers: manufacturing and applications for pulmonary route. Expert Opin Drug Deliv 9(9):1111–1127
Jee J-P, Lim S-J, Park J-S, Kim C-K (2006) Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles. Eur J Pharm Biopharm 63(2):134–139
Jenning V, Gysler A, Schäfer-Korting M, Gohla S (2000a) Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 49(3):211–218
Jenning V, Schäfer-Korting M, Gohla S (2000b) Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Controlled Release 66(2–3):115–126
Jenning V, Thünemann A, Gohla S (2000c) Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 199(2):167–177
Jia L, Shen J, Zhang D, Duan C, Liu G, Zheng D et al (2012) In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Int J Biol Macromol 50(3):523–529
Joshi M, Müller R (2009) Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 71(2):161–172
Kim C-J (2004) Surface chemistry and colloids. Advanced pharmaceutics. CRC Press, Boca Raton
Kovacevic A, Müller R, Savic S, Vuleta G, Keck C (2014) Solid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: preparation, characterization and physical stability investigation. Colloid Surf A 444:15–25
Kovacevic A, Savic S, Vuleta G, Müller R, Keck C (2011) Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. Int J Pharm 406(1–2):163–172
Kumar S, Randhawa J (2013) Preparation and characterization of paliperidone loaded solid lipid nanoparticles. Colloid Surf B 102:562–568
Lawler P, Dimick P (2002) Crystallization and polymorphism of fats. In: Akoh C, Min D (eds) Food lipids: chemistry, nutrition and biotechnology. Marcel Dekker, New York, pp 275–300
Liu D, Ge Y, Tang Y, Yuan Y, Zhang Q, Li R et al (2010) Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies. J Microencapsul 27(8):726–734
Liu D, Liu Z, Wang L, Zhang C, Zhang N (2011) Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloid Surf B 85(2):262–269
Liu J, Gong T, Fu H, Wang C, Wang X, Chen Q et al (2008) Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 356(1–2):333–344
Lukowski G, Kasbohm J, Pflegel P, Illing A, Wulff H (2000) Crystallographic investigation of cetylpalmitate solid lipid nanoparticles. Int J Pharm 196(2):201–205
Mengersen F, Bunjes H (2012) Chemical stability of phospholipid-stabilized supercooled smectic cholesteryl myristate nanoparticle. Eur J Pharm Biopharm 82(2):262–271
Mitri K, Shegokar R, Gohla S, Anselmi C, Müller R (2011) Lipid nanocarriers for dermal delivery of lutein: Preparation, characterization, stability and performance. Int J Pharm 414(1–2):267–275
Muchow M, Maincent P, Müller R (2008) Lipid nanoparticles with a solid matrix (SLN®, NLC®, LDC®) for oral drug delivery. Drug Dev Ind Pharm 34(12):1394–1405
MĂĽller R, Freitas C, zur MĂĽhlen A, Mehnert W (1996) Solid lipid nanoparticles (SLN) for controlled drug delivery. Eur J Pharm Sci 4(Suppl 1(0)):S75
Müller R, Keck C (2004) Challenges and solutions for the delivery of biotech drugs—a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol 113(1–3):151–170
Müller R, Radtke M, Wissing S (2002) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliver Rev 54:S131–S155
Nik A, Langmaid S, Wright A (2012) Nonionic surfactant and interfacial structure impact crystallinity and stability of β-carotene loaded lipid nanodispersions. J Agric Food Chem 60(16):4126–4135
Nutan M, Reddy I (2009) General Principles of Suspensions. In: Kulshreshtha A, Singh O, Wall G (eds) Pharmaceutical suspensions—from pharmaceutical development to manufacturing. Springer, New York
Ohki S, Ohshima H (1999) Interaction and aggregation of lipid vesicles (DLVO theory versus modified DLVO theory). Colloid Surf B 14(1–4):27–45
Ohshima H, Miyagishima A, Kurita T, Makino Y, Iwao Y, Sonobe T et al (2009) Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution. Int J Pharm 377(1–2):180–184
Rabinow B (2004) Nanosuspensions in drug delivery. Nat Rev Drug Discovery 3(9):785–796
Radomska-Soukharev A (2007) Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliver Rev 59(6):411–418
Saupe A, Gordon K, Rades T (2006) Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int J Pharm 314(1):56–62
Scheler S (2012) Micro- and nano-sizing of poorly soluble drugs by grinding techniques. In: Douroumis D, Fahr A (eds) Drug delivery strategies for poorly water-soluble drugs. Wiley, West Sussex
Shah R, Malherbe F, Eldridge D, Palombo E, Harding I (2014) Physicochemical characterization of solid lipid nanoparticles (SLNs) prepared by a novel microemulsion technique. J Colloid Interface Sci 428:286–294
Silva A, Amaral M, González-Mira E, Santos D, Ferreira D (2012) Solid lipid nanoparticles (SLN)—based hydrogels as potential carriers for oral transmucosal delivery of risperidone: Preparation and characterization studies. Colloid Surf B 93:241–248
Silva A, González-Mira E, GarcĂa M, Egea M, Fonseca J, Silva R et al (2011) Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloid Surf B 86(1):158–165
Soares S, Fonte P, Costa A, Andrade J, Seabra V, Ferreira D et al (2013) Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles. Int J Pharm 456(3):370–381
Souto E, Almeida A, Müller R (2007) Lipid nanoparticles (SLN, NLC) for cutaneous drug delivery: structure, protection and skin effects. J Biomed Nanotechnol 3(4):317–331
Souto E, Wissing S, Barbosa C, Müller R (2004) Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur J Pharm Biopharm 58(1):83–90
Tamjidi F, Shahedi M, Varshosaz J, Nasirpour A (2013) Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules. Innov Food Sci Emerg 19:29–43
Tan S, Billa N (2014) Lipid effects on expulsion rate of amphotericin B from solid lipid nanoparticles. AAPS Pharm Sci Technol 15(2):287–295
Teeranachaideekul V, Müller R, Junyaprasert V (2007) Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)—effects of formulation parameters on physicochemical stability. Int J Pharm 340(1–2):198–206
Tsai M-J, Wu P-C, Huang Y-B, Chang J-S, Lin C-L, Tsai Y-H et al (2012) Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm 423(2):461–470
Van Oss C, Good R, Chaudhury M (1986) The role of van der Waals forces and hydrogen bonds in “hydrophobic interactions” between biopolymers and low energy surfaces. J Colloid Interface Sci 111(2):378–390
Varshosaz J, Eskandari S, Tabbakhian M (2012) Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants. Carbohydr Polym 88(4):1157–1163
Verwey E (1947) Theory of the stability of lyophobic colloids. J Phys Colloid Chem 51(3):631–636
Vivek K, Reddy H, Murthy R (2007) Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS Pharm Sci Technol 8(4):16–24
Walstra P (1993) Principles of emulsion formation. Chem Eng Sci 48(2):333–349
Westesen K, Bunjes H (1995) Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix? Int J Pharm 115(1):129–131
Westesen K, Bunjes H, Koch M (1997) Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 48(2):223–236
Wong H, Wu X, Bendayan R (2012) Nanotechnological advances for the delivery of CNS therapeutics. Adv Drug Deliver Rev 64:686–700
Wu L, Zhang J, Watanabe W (2011) Physical and chemical stability of drug nanoparticles. Adv Drug Deliver Rev 63(6):456–469
Yang W, Peters J, Williams R III (2008) Inhaled nanoparticles—a current review. Int J Pharm 356(1–2):239–247
Zimmermann E, Müller R, Mäder K (2000) Influence of different parameters on reconstitution of lyophilized SLN. Int J Pharm 196(2):211–213
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2015 The Author(s)
About this chapter
Cite this chapter
Shah, R., Eldridge, D., Palombo, E., Harding, I. (2015). Physicochemical Stability. In: Lipid Nanoparticles: Production, Characterization and Stability. SpringerBriefs in Pharmaceutical Science & Drug Development. Springer, Cham. https://doi.org/10.1007/978-3-319-10711-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-10711-0_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-10710-3
Online ISBN: 978-3-319-10711-0
eBook Packages: MedicineMedicine (R0)